TIEG1 negatively controls the myoblast pool indispensable for fusion during myogenic differentiation of C2C12 cells. 2011

Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
Laboratory of Functional Morphology, Department of Animal Biology, Graduate School of Agricultural Science, Tohoku University, 1-1 Tsutsumidori-Amamiyamachi, Aoba-ku, Sendai 981-8555, Japan.

The transforming growth factor (TGF)-β inducible early gene (TIEG)-1 is implicated in the control of cell proliferation, differentiation, and apoptosis in some cell types. Since TIEG1 functioning may be associated with TGF-β, a suppressor of myogenesis, TIEG1 is also likely to be involved in myogenesis. Therefore, we investigated the function of TIEG1 during myogenic differentiation in vitro using the murine myoblasts cell line, C2C12. TIEG1 expression increased during differentiation of C2C12 cells. Constitutive expression of TIEG1 reduced survival and decreased myotube formation. Conversely, knocking down TIEG1 expression increased the number of viable cells during differentiation, and accelerated myoblast fusion into multinucleated myotubes. However, expression of the myogenic differentiation marker, myogenin, remained unaffected by TIEG1 knockdown. The mechanism underlying these events was investigated by focusing on the regulation of myoblast numbers after induction of differentiation. The knockdown of TIEG1 led to changes in cell cycle status and inhibition of apoptosis during the initial stages of differentiation. Microarray and real-time PCR analyses showed that the regulators of cell cycle progression were highly expressed in TIEG1 knockdown cells. Therefore, TIEG1 is a negative regulator of the myoblast pool that causes inhibition of myotube formation during myogenic differentiation.

UI MeSH Term Description Entries
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002459 Cell Fusion Fusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization. Cell Fusions,Fusion, Cell,Fusions, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
July 2020, Biology open,
Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
June 2008, Genes to cells : devoted to molecular & cellular mechanisms,
Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
July 2020, Biochemical and biophysical research communications,
Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
November 2012, Biochemical and biophysical research communications,
Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
May 2012, Development (Cambridge, England),
Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
April 2015, Molecules and cells,
Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
July 2005, Molecular & cellular proteomics : MCP,
Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
April 2019, Scientific reports,
Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
January 2015, Biochemical and biophysical research communications,
Masato Miyake, and Shinichiro Hayashi, and Shunsuke Iwasaki, and Takafumi Uchida, and Kouichi Watanabe, and Shyuichi Ohwada, and Hisashi Aso, and Takahiro Yamaguchi
April 2010, Cellular signalling,
Copied contents to your clipboard!